Skip to content

Mitral Valve Prolapse Myxomatous 3 C1835814

Published: July 22, 2026Updated: August 25, 2026

A heart valve condition where the mitral valve becomes thickened and floppy, potentially causing blood to leak backward. Many people have no symptoms and live normal lives. Regular monitoring and managing symptoms are typically sufficient.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Chest discomfort or palpitations

(cardiovascular)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Dyspnea

(cardiovascular)

Fatigue

(cardiovascular)

Exercise intolerance

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular echocardiographic monitoring

Serial echocardiograms to assess mitral valve function, leaflet thickness, and regurgitation severity over time. This allows for tracking disease progression and timely intervention if needed.

monitoring
3

Stimulant avoidance and stress management

Avoiding excessive caffeine, alcohol, and nicotine which can trigger palpitations. Implementing stress-reduction techniques such as meditation, yoga, or deep breathing exercises to minimize cardiac symptoms.

lifestyle

Additional treatment options

Beta-blocker therapy for symptom control

Prescription beta-blockers may be considered for patients experiencing palpitations, chest discomfort, or anxiety related to MVP. These medications help regulate heart rate and reduce adrenergic symptoms.

medication

Antibiotic prophylaxis assessment

Evaluation of need for antibiotic prophylaxis before certain dental or surgical procedures based on current valve function. Recommendations have evolved, so individual assessment is important.

medication

Patient education and anxiety management

Providing education about the generally benign nature of MVP and reassurance about prognosis. Cognitive behavioral therapy or counseling may help patients experiencing anxiety-related symptoms.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitral Valve Prolapse Myxomatous 3 C1835814?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2021.

guideline2021
2

El-Tamrani H, J做题 O. Myxomatous Degeneration of the Mitral Valve: Pathophysiology and Clinical Implications. Prog Cardiovasc Dis. 2020.

review2020
3

Dejgaard LA, Hellevik LR, Haugaa KH. Long-term Outcomes of Mitral Valve Prolapse: A Population-Based Cohort Study. Eur Heart J. 2019.

clinical_trial2019
4

Bhattacharyya S, Lloyd G. Echocardiographic Assessment of Myxomatous Mitral Valve Disease. Heart Lung Circ. 2022.

review2022

Medication Comparisons

Compare medications used to treat Mitral Valve Prolapse Myxomatous 3 C1835814. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy